OMX Stockholm 30
2.779,44
PKT
+21,28
PKT
+0,77
%
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.01.20 | Hennes Mauritz (H M, H&M) Sell | UBS AG | |
| 30.01.20 | Volvo (B) Sell | UBS AG | |
| 30.01.20 | Ericsson (Telefon L.M.Ericsson) (B) overweight | Barclays Capital | |
| 30.01.20 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 30.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 28.01.20 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 28.01.20 | AstraZeneca buy | Deutsche Bank AG | |
| 27.01.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.01.20 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy | Goldman Sachs Group Inc. | |
| 27.01.20 | Ericsson (Telefon L.M.Ericsson) (B) kaufen | Credit Suisse Group | |
| 27.01.20 | Ericsson (Telefon L.M.Ericsson) (B) buy | Kepler Cheuvreux | |
| 23.01.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 20.01.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 17.01.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.01.20 | Volvo (B) Sell | UBS AG | |
| 16.01.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 16.01.20 | AstraZeneca overweight | Barclays Capital | |
| 16.01.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 16.01.20 | Ericsson (Telefon L.M.Ericsson) (B) overweight | Barclays Capital | |
| 14.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 13.01.20 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.01.20 | Volvo (B) Sell | UBS AG | |
| 06.01.20 | AstraZeneca neutral | Morgan Stanley | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 02.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 19.12.19 | Volvo (B) buy | Kepler Cheuvreux | |
| 18.12.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 17.12.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 17.12.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.12.19 | AstraZeneca Sell | UBS AG | |
| 12.12.19 | AstraZeneca buy | Deutsche Bank AG | |
| 11.12.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.12.19 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 10.12.19 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 09.12.19 | AstraZeneca Sell | UBS AG | |
| 09.12.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.12.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.